This company seems to have been delisted
Reason: Merged with Viewpoint Molecular
Last recorded trade on: April 21, 2023
Source: https://isoray.com/2023/02/isoray-completes-merger-with-viewpoint-molecular-targeting-to-advance-new-treatment-paradigm-in-targeted-precision-oncology-medicine/
Reason: Merged with Viewpoint Molecular
Last recorded trade on: April 21, 2023
Source: https://isoray.com/2023/02/isoray-completes-merger-with-viewpoint-molecular-targeting-to-advance-new-treatment-paradigm-in-targeted-precision-oncology-medicine/
Isoray
ISR
$0.63
Share price
0.00%
Change (1 day)
49.60%
Change (1 year)
Categories
Earnings for Isoray (ISR)
Earnings in 2022 (TTM): -A$16.07 Million
According to Isoray 's latest financial reports the company's current earnings are A$8.96 Million. a decrease over its 2021 earnings that were of -A$9.53 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Isoray from 2002 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022  | -A$17.99 Million | 88.92% |
| 2021 | -A$9.53 Million | 73.83% |
| 2020 | -A$5.48 Million | -18.04% |
| 2019 | -A$6.69 Million | -39.3% |
| 2018 | -A$11.02 Million | 6.45% |
| 2017 | -A$10.35 Million | 15.87% |
| 2016 | -A$8.93 Million | 23.21% |
| 2015 | -A$7.25 Million | -19.51% |
| 2014 | -A$9.01 Million | 39.56% |
| 2013 | -A$6.46 Million | |
| 2011 | -A$4.99 Million | -21.06% |
| 2010 | -A$6.32 Million | -16.36% |
| 2009 | -A$7.55 Million | -36.85% |
| 2008 | -A$11.95 Million | -29.02% |
| 2007 | -A$16.84 Million | 17.75% |
| 2006 | -A$14.3 Million | |
| 2004 | -A$0.03 Million | 16.83% |
| 2003 | -A$0.03 Million | 5.33% |
| 2002 | -A$0.03 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | A$15.65 M | -187.04% | 🇺🇸 USA |
 | -A$69.47 Million | 286.15% | 🇺🇸 USA |
 | A$1.73 B | -9,719.94% | 🇺🇸 USA |
 | A$14.03 B | -78,131.76% | 🇺🇸 USA |